We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
Cap. Flow
+$49.6M
Cap. Flow %
0.52%
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198

Top Sells

Rank Stock Value
1
DOC icon
Healthpeak Properties
DOC
+$48.2M
2
CLC
Clarcor
CLC
+$15.4M
3
AMGN icon
Amgen
AMGN
+$11.3M
4
AAPL icon
Apple
AAPL
+$9.79M
5
NUE icon
Nucor
NUE
+$8.91M

Sector Composition

Rank Sector Weight
1 Financials 15.52%
2 Healthcare 14.53%
3 Technology 12.08%
4 Consumer Staples 11.47%
5 Industrials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNH
626
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.54M 0.02%
33,589
-8,485
-20% -$422K
K
627
DELISTED
Kellanova
K
$1.54M 0.02%
22,560
-1,425
-6% -$98.4K
TGNA
628
DELISTED
TEGNA Inc
TGNA
$1.54M 0.02%
93,811
+580
+0.6% +$8.92K
LHO
629
DELISTED
LaSalle Hotel Properties
LHO
$1.53M 0.02%
52,738
-5,376
-9% -$160K
MSCC
630
DELISTED
Microsemi Corp
MSCC
$1.53M 0.02%
29,621
-6,392
-18% -$343K
CIT
631
DELISTED
CIT Group Inc.
CIT
$1.51M 0.02%
35,286
+405
+1% +$17.2K
LGND icon
632
Ligand Pharmaceuticals
LGND
$6.02B
$1.5M 0.02%
22,769
-5,383
-19% -$354K
XRX icon
633
Xerox
XRX
$337M
$1.5M 0.02%
51,192
-48,686
-49% -$1.41M
DG icon
634
Dollar General
DG
$25.9B
$1.5M 0.02%
21,505
-1,528
-7% -$112K
OLN icon
635
Olin
OLN
$2.64B
$1.5M 0.02%
45,532
-9,778
-18% -$293K
UMPQ
636
DELISTED
Umpqua Holdings Corp
UMPQ
$1.49M 0.02%
84,012
-9,334
-10% -$172K
GWPH
637
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.48M 0.02%
12,263
-188
-2% -$23.1K
LH icon
638
Labcorp
LH
$24.3B
$1.48M 0.02%
12,025
+80
+0.7% +$9.47K
MNK
639
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.48M 0.02%
33,133
+1,259
+4% +$62.1K
DFT
640
DELISTED
DuPont Fabros Technology Inc.
DFT
$1.47M 0.02%
29,722
-2,215
-7% -$107K
SUI icon
641
Sun Communities
SUI
$15B
$1.47M 0.02%
18,304
+761
+4% +$60.6K
TAP icon
642
Molson Coors Class B
TAP
$7.68B
$1.47M 0.02%
15,345
-987
-6% -$96.4K
FR icon
643
First Industrial Realty Trust
FR
$8.88B
$1.47M 0.02%
55,060
-5,706
-9% -$153K
HWC icon
644
Hancock Whitney
HWC
$6.13B
$1.47M 0.02%
32,167
-1,626
-5% -$74.2K
IRWD icon
645
Ironwood Pharmaceuticals
IRWD
$611M
$1.47M 0.02%
102,548
-25,726
-20% -$352K
GRFS
646
Grifois
GRFS
$5.16B
$1.46M 0.02%
77,573
-18,586
-19% -$323K
CBPO
647
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$1.45M 0.02%
14,510
-3,419
-19% -$365K
PTLA
648
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.45M 0.02%
37,051
-9,027
-20% -$287K
GPT
649
DELISTED
Gramercy Property Trust
GPT
$1.44M 0.02%
54,775
-4,985
-8% -$134K
ALLY icon
650
Ally Financial
ALLY
$13.1B
$1.44M 0.02%
70,632
+4,476
+7% +$95K

Similar funds

ProShare Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
  • ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
  • ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
  • ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
  • ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
  • ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.